European Biotechs AbTx and Big Picture Bio Raise Seed Funding for Cancer Therapies
French startup AbTx secured €1.7 million while London-based Big Picture Bio emerged from stealth with €2.55 million, both targeting new approaches to cancer treatment.
AfroEuropa Newsroom
AfroEuropa desk
Two European biotech startups have announced early-stage funding to develop cancer therapies, according to reports from Ventureburn and EU-Startups.
AbTx, a French biotech founded in 2024, raised €1.7 million (about $2 million) in a seed round, as reported by Ventureburn. The company focuses on precision treatments for solid tumors that have not responded to standard care. The funding is intended to support clinical development of its patented Therano-Stick platform, which uses enzymatic bio-conjugation to produce miniaturised antibody-drug conjugates, referred to by the company as fragment drug conjugates. AbTx also received the i-Lab award, which Ventureburn described as public validation for its oncology platform.
Keep reading
Three Startups Across MENA, US and Europe Secure Fresh Funding
Paymob, Corridor and Spott announced funding rounds spanning payments infrastructure, AI health benefits and recruitment software.
Other highlights
Xiaomi 18 Pro Series Reveals Dual 200MP Cameras Ahead of China Launch
Xiaomi has detailed the rear camera systems of its upcoming 18 Pro and 18 Pro Max, both fitted with two 200MP sensors, ahead of a September 23 launch in China.
Follow the story
One newsletter, two continents
The Bridge brings you the tech, startups, and leaders moving between Africa and Europe in one sharp email each morning. No spam, unsubscribe anytime.
